Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 1 May 2009

Geretti Anna Maria, Harrison Linda, Green Hannah, Sabin Caroline, Hill Teresa, Fearnhill Esther, Pillay Deenan, Dunn David

Abstract excerpt

BACKGROUND: It has been proposed that subtype-related human immunodeficiency virus type 1 (HIV-1) variability may influence virologic and immunologic responses to highly active antiretroviral therapy (HAART). Studies to date, however, have described treatment outcomes predominantly in persons with subtype B infection or compared subtype B with diverse non-B subtypes grouped together. METHODS: With use of data...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to HIV Infections

Share to Treatment Outcome

Share to United Kingdom

Share to Viral Load

Source

Identifiers

PMID: 19331585
DOI: 10.1086/598502

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy.PMID 19331585Read ↗

Impact of HIV-1 viral subtype on disease progression and response to antiretroviral therapy.Semantic proximity Read ↗

HIV-1 subtypes: epidemiology and significance for HIV managementSemantic proximity Read ↗

Mortality of treated HIV-1 positive individuals according to viral subtype in Europe and Canada: collaborative cohort analysis.Semantic proximity Read ↗

Evaluating immunologic response and clinical deterioration in treatment-naive patients initiating first-line therapies infected with HIV-1 CRF01_AE and subtype B.Semantic proximity Read ↗

Do HIV-1 non-B subtypes differentially impact resistance mutations and clinical disease progression in treated populations? Evidence from a systematic review.Semantic proximity Read ↗

Does genetic diversity of HIV-1 non-B subtypes differentially impact disease progression in treatment-naive HIV-1-infected individuals? A systematic review of evidence: 1996-2010.Semantic proximity Read ↗

Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B.Semantic proximity Read ↗

Impact of HIV-1 subtype on CD4 count at HIV seroconversion, rate of decline, and viral load set point in European seroconverter cohorts.Semantic proximity Read ↗

Virologic and immunologic response to cART by HIV-1 subtype in the CASCADE collaboration.Semantic proximity Read ↗

The impact of HIV-1 subtype on the clinical response on HAART.Semantic proximity Read ↗

HIV-1 subtype B/B' and baseline drug resistance mutation are associated with virologic failure: a multicenter cohort study in China.Semantic proximity Read ↗

Impact of pre-therapy viral load on virological response to modern first-line HAART.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.